| Leiomyosarcoma studied in …STUDIED_INderived135 of 135show fewer |
|---|
| → studied in | NCT06498648Phase 1/Phase 2 · recruiting Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma · condition mapped CURATED_BROADER · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06524583Phase 2 · recruiting Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour · condition mapped ALIAS · 135 trials mapped (45 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02923778Phase 2 · active not recruiting Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06308419Phase 1 · active not recruiting A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04031677Phase 3 · recruiting Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05711615Phase 1 · recruiting Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma · condition mapped CURATED_BROADER · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05099666Phase 1/Phase 2 · active not recruiting Lurbinectedin + Doxorubicin In Leiomyosarcoma · condition mapped CURATED_BROADER · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07516925Phase 2 · recruiting A Study of Ivonescimab in People With Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06975293Phase 1/Phase 2 · recruiting STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05827614Phase 1 · terminated Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03851614Phase 2 · active not recruiting Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04554914Phase 2 · active not recruiting A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07628634early Phase 1 · recruiting Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07633756Phase 1 · recruiting A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05227326Phase 1 · recruiting AOH1996 for the Treatment of Refractory Solid Tumors · condition mapped ALIAS · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04624178Phase 2 · active not recruiting A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04925089recruiting Localized Leiomyosarcoma Biomarker Protocol · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01012297Phase 3 · terminated Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05653388recruiting Metastatic Leiomyosarcoma Biomarker Protocol · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06088290Phase 3 · active not recruiting Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo) · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06571734Phase 2 · recruiting XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma · condition mapped CURATED_BROADER · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02180867Phase 2/Phase 3 · completed Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06789172Phase 1 · recruiting A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06957431Phase 1 · recruiting Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma · condition mapped CURATED_BROADER · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07467772Phase 2 · recruiting Ph 2 Elacestrant in ER Positive Uterine Sarcomas · condition mapped ALIAS · 135 trials mapped (45 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04807816Phase 2 · completed Targeting ATR in Soft-tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Adult Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04200443Phase 2 · active not recruiting Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma · condition mapped CURATED_BROADER · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05836571Phase 2 · active not recruiting Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma · condition mapped CURATED_BROADER · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06638931Phase 2 · recruiting Agnostic Therapy in Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04383119Phase 2 · recruiting Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma · condition mapped ALIAS · 135 trials mapped (45 active) | — | — | Ovarian Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04420975Phase 1 · active not recruiting Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03016819Phase 3 · recruiting Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07432932recruiting Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04055220NA · recruiting Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07169344Phase 2 · recruiting Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07173972Phase 2 · recruiting Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma. · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06849986Phase 2 · recruiting IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03526679Phase 1/Phase 2 · completed Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06528769Phase 2 · recruiting Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03899805Phase 2 · completed A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04242238Phase 1 · completed Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05080790Phase 2 · completed Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06277154Phase 2 · recruiting MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06299163Phase 1 · terminated NM32-2668 in Adult Patients With Selected Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05269355Phase 2/Phase 3 · terminated A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS) · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06875700recruiting Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05427461NA · active not recruiting Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma, Part 2 · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01793168recruiting Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04811196Phase 1 · completed A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05166577Phase 1 · terminated Nanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPC · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | EBV-Related Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02428192Phase 2 · completed Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma · condition mapped CURATED_BROADER · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04535271Phase 2 · recruiting Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03241745Phase 2 · completed A Study of Nivolumab in Selected Uterine Cancer Patients · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01956084Phase 1 · completed Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04996004Phase 2 · terminated A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06526897NA · not yet recruiting Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06521060not yet recruiting The Role of Pre-Surgical Tru - Cut Biopsy in the Management of Atypical Myometrial Lesions · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03926936Phase 2 · completed FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study · condition mapped ALIAS · 135 trials mapped (45 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03670069Phase 1 · terminated Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas · condition mapped CURATED_BROADER · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03761095Phase 1 · completed A Study of Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS) · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06244251NA · active not recruiting Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids · condition mapped ALIAS · 135 trials mapped (45 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02940041terminated Concordance Between Sonography Amd MRI for Presurgical Diagnosis of Uterine Mesenchymal Malignant Tumors · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06170177recruiting Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Bladder Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05116683Phase 2 · terminated ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02584309Phase 2 · completed Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05094804Phase 1/Phase 2 · unknown A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03420014Phase 2 · unknown Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA) · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05174455Phase 2 · withdrawn Niraparib for the Treatment of Leiomyosarcoma · condition mapped CURATED_BROADER · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01958580NA · terminated Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03009201Phase 1 · completed Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03718091Phase 2 · completed M6620 (VX-970) in Selected Solid Tumors · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02822495no longer available Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02275286Phase 1/Phase 2 · recruiting Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05548179unknown Exploring Clinical Trial Experiences of People With Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03959033terminated Patient Reported Outcome Measures (PROMs) With Trabectedin · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02601209Phase 1/Phase 2 · terminated Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma · condition mapped CURATED_BROADER · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074318Phase 1/Phase 2 · terminated Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00346164Phase 3 · completed Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Adult Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05204524NA · unknown Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05116800Phase 2 · withdrawn Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02247544Phase 2 · completed Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01532687Phase 2 · completed Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Adult Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04935333unknown Accuracy of the Preoperative Molecular Diagnosis of Uterine Tumors by Liquid Biopsy · condition mapped ALIAS · 135 trials mapped (45 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04214457unknown Development of a Predictive Model for Early Differential Diagnosis of Uterine Leiomyomas and Leiomyosarcomas · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04099277Phase 1 · terminated A Study of LY3435151 in Participants With Solid Tumors · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04906876Phase 2 · withdrawn A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03989596Phase 2 · unknown Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03651375Phase 2 · unknown Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03509207Phase 2 · terminated Vorinostat (SAHA) in Uterine Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00062868Phase 1 · completed LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01533207Phase 3 · terminated Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01447056Phase 1 · completed Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01442662Phase 2 · completed Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patient With Metastatic or Relapsed Uterine · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01220609Phase 2 · completed Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025220Phase 2 · completed Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00378911Phase 2 · completed Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus · condition mapped ALIAS · 135 trials mapped (45 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01637961Phase 2 · completed Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03773510Phase 3 · withdrawn Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With Trabectedin · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03437070Phase 1 · withdrawn Trabectedin, Doxorubicin and Olaratumab in Patients With Metastatic or Recurrent Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02303262Phase 2 · completed SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma · condition mapped CURATED_BROADER · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01614795Phase 2 · completed Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Childhood Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00414076Phase 2 · terminated Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01154452Phase 1/Phase 2 · completed Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Adult Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00668148Phase 2 · completed A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02983539unknown Detection of Circulating Tumor Cells in Patients With Sarcomas · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00659360Phase 2 · completed AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Adult Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01418001Phase 1/Phase 2 · terminated Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02249702Phase 2 · completed Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01653028Phase 2 · completed Alisertib in Treating Patients With Advanced or Metastatic Sarcoma · condition mapped CURATED_BROADER · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112463Phase 2 · completed Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Adult Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00356031Phase 2 · completed Bevacizumab and Radiation Therapy for Sarcomas · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00856050Phase 2 · completed Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00815945Phase 2 · completed Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00031629Phase 2 · completed Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00897442completed Collecting Tumor Samples From Patients With Gynecological Tumors · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01343277Phase 3 · completed A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720174Phase 1 · completed Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Adult Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01567046completed Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Childhood Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00887809Phase 2 · completed Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00614835NA · completed Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus · condition mapped ALIAS · 135 trials mapped (45 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00390234Phase 2 · completed Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma · condition mapped ALIAS · 135 trials mapped (45 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00837148Phase 2 · completed Sorafenib and Dacarbazine in Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02587169Phase 1/Phase 2 · unknown Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Retroperitoneal Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397384Phase 1 · completed Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer · condition mapped ALIAS · 135 trials mapped (45 active) | — | — | Small Intestinal Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093080Phase 2 · completed Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED) · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01426633Phase 1 · completed Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00282087Phase 2 · completed Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00503295Phase 2 · completed Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00060944Phase 2 · completed A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00245102Phase 2 · completed Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Adult Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003292Phase 2 · terminated S9624 Ifosfamide in Treating Patients With Meningeal Tumors · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Adult Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00031681Phase 1 · completed 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) · condition mapped ALIAS · 135 trials mapped (45 active) | — | — | Small Intestinal Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087191NA · terminated EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer · condition mapped ALIAS · 135 trials mapped (45 active) | — | — | Small Intestinal Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00400569Phase 2 · completed Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 135 trials mapped (45 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |